Wei Meng

This research covers molecular mechanisms of disease, spanning cancer biology (prostate cancer, glioblastoma, hepatocellular carcinoma, leukemia), inflammatory and autoimmune conditions (ulcerative colitis, allergic rhinitis), and cardiovascular/metabolic disorders (hypertension, atherosclerosis). Common approaches include studying gene regulation (DNA methylation, circular RNAs, microRNAs), cell signaling pathways, and using large-scale sequencing data (single-cell and bulk RNA-seq) to identify disease mechanisms and potential drug targets. The work is highly interdisciplinary, combining bioinformatics, molecular biology, and clinical data analysis across many different disease areas rather than focusing on one narrow topic.

Publication output was relatively low and variable from 2017-2022, then spiked dramatically in 2023 before settling to a more moderate but still elevated pace in 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026